2022
DOI: 10.12669/pjms.38.5.5092
|View full text |Cite
|
Sign up to set email alerts
|

Expressions of HIF-1α and MiR-210 in aqueous humor of patients with central retinal vein occlusion combined with macular edema

Abstract: Objectives: To detect the expressions of hypoxia-inducible factor 1α (HIF-1α) and microRNA-210 (miR-210) in the aqueous humor of patients with central retinal vein occlusion (CRVO) combined with macular edema, and explore their correlations with CRVO combined with macular edema. Methods: A total of 65 patients (65 eyes) with CRVO combined with macular edema who were treated in the Lixiang Eye Hospital of Soochow University from April 2018 to March 2020 were selected as subjects (CRVO combined with macula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Retinal vein occlusion (RVO) is a common vascular disease of the ocular fundus in the clinic, including branch retinal vein occlusion (RVO) and central retinal vein occlusion (CRVO), the latter of which has a relatively low incidence but a relatively poor visual prognosis and a higher likelihood of developing neovascular glaucoma. 1,2 According to an epidemiological investigation, secondary macular edema is the main cause of vision loss and even blindness in patients with ischemic RVO, which has a serious impact on the daily life of patients. 3,4 Therefore, timely and effective treatment is conducive to improving the prognosis of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Retinal vein occlusion (RVO) is a common vascular disease of the ocular fundus in the clinic, including branch retinal vein occlusion (RVO) and central retinal vein occlusion (CRVO), the latter of which has a relatively low incidence but a relatively poor visual prognosis and a higher likelihood of developing neovascular glaucoma. 1,2 According to an epidemiological investigation, secondary macular edema is the main cause of vision loss and even blindness in patients with ischemic RVO, which has a serious impact on the daily life of patients. 3,4 Therefore, timely and effective treatment is conducive to improving the prognosis of patients.…”
Section: Introductionmentioning
confidence: 99%